Repositioning Candidate Details

Candidate ID: R0050
Source ID: DB00147
Source Type: experimental; nutraceutical
Compound Type: small molecule
Compound Name: Pyridoxal
Synonyms: 2-methyl-3-hydroxy-4-formyl-5-hydroxymethylpyridine; 3-hydroxy-5-(hydroxymethyl)-2-methyl-4-pyridinecarboxaldehyde; 3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde; 3-hydroxy-5-(hydroxymethyl)-2-methylpyridine-4-carboxaldehyde; Piridoxal; Pyridoxaldehyde
Molecular Formula: C8H9NO3
SMILES: CC1=NC=C(CO)C(C=O)=C1O
Structure:
DrugBank Description: The 4-carboxyaldehyde form of vitamin B 6 which is converted to pyridoxal phosphate which is a coenzyme for synthesis of amino acids, neurotransmitters (serotonin, norepinephrine), sphingolipids, aminolevulinic acid.
CAS Number: 66-72-8
Molecular Weight: 167.162
DrugBank Indication: Pyridoxal is one of the natural forms available of vitamin B6, therefore, it is used for nutritional supplementation and for treating dietary shortage or imbalances.
DrugBank Pharmacology: Pyridoxal principally in the form of the coenzyme pyridoxal 5'-phosphate, is involved in a wide range of biochemical reactions, including the metabolism of amino acids and glycogen, the synthesis of nucleic acids, hemogloblin, sphingomyelin and other sphingolipids, and the synthesis of the neurotransmitters serotonin, dopamine, norepinephrine and gamma-aminobutyric acid (GABA).
DrugBank MoA: Pyridoxal is the precursor to pyridoxal phosphate. Pyridoxal 5'-phosphate is involved in a wide range of biochemical reactions, including the metabolism of amino acids and glycogen, the synthesis of nucleic acids, hemogloblin, sphingomyelin and other sphingolipids, and the synthesis of the neurotransmitters serotonin, dopamine, norepinephrine and gamma-aminobutyric acid (GABA).
Targets: Pyridoxal kinase
Inclusion Criteria: Indication associated